Cargando…
The Role of Initial Oligomers in Amyloid Fibril Formation by Human Stefin B
Oligomers are commonly observed intermediates at the initial stages of amyloid fibril formation. They are toxic to neurons and cause decrease in neural transmission and long-term potentiation. We describe an in vitro study of the initial steps in amyloid fibril formation by human stefin B, which pro...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794784/ https://www.ncbi.nlm.nih.gov/pubmed/24013380 http://dx.doi.org/10.3390/ijms140918362 |
_version_ | 1782287256450498560 |
---|---|
author | Taler-Verčič, Ajda Kirsipuu, Tiina Friedemann, Merlin Noormägi, Andra Polajnar, Mira Smirnova, Julia Žnidarič, Magda Tušek Žganec, Matjaž Škarabot, Miha Vilfan, Andrej Staniforth, Rosemary A. Palumaa, Peep Žerovnik, Eva |
author_facet | Taler-Verčič, Ajda Kirsipuu, Tiina Friedemann, Merlin Noormägi, Andra Polajnar, Mira Smirnova, Julia Žnidarič, Magda Tušek Žganec, Matjaž Škarabot, Miha Vilfan, Andrej Staniforth, Rosemary A. Palumaa, Peep Žerovnik, Eva |
author_sort | Taler-Verčič, Ajda |
collection | PubMed |
description | Oligomers are commonly observed intermediates at the initial stages of amyloid fibril formation. They are toxic to neurons and cause decrease in neural transmission and long-term potentiation. We describe an in vitro study of the initial steps in amyloid fibril formation by human stefin B, which proved to be a good model system. Due to relative stability of the initial oligomers of stefin B, electrospray ionization mass spectrometry (ESI MS) could be applied in addition to size exclusion chromatography (SEC). These two techniques enabled us to separate and detect distinguished oligomers from the monomers: dimers, trimers, tetramers, up to decamers. The amyloid fibril formation process was followed at different pH and temperatures, including such conditions where the process was slow enough to detect the initial oligomeric species at the very beginning of the lag phase and those at the end of the lag phase. Taking into account the results of the lower-order oligomers transformations early in the process, we were able to propose an improved model for the stefin B fibril formation. |
format | Online Article Text |
id | pubmed-3794784 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-37947842013-10-21 The Role of Initial Oligomers in Amyloid Fibril Formation by Human Stefin B Taler-Verčič, Ajda Kirsipuu, Tiina Friedemann, Merlin Noormägi, Andra Polajnar, Mira Smirnova, Julia Žnidarič, Magda Tušek Žganec, Matjaž Škarabot, Miha Vilfan, Andrej Staniforth, Rosemary A. Palumaa, Peep Žerovnik, Eva Int J Mol Sci Article Oligomers are commonly observed intermediates at the initial stages of amyloid fibril formation. They are toxic to neurons and cause decrease in neural transmission and long-term potentiation. We describe an in vitro study of the initial steps in amyloid fibril formation by human stefin B, which proved to be a good model system. Due to relative stability of the initial oligomers of stefin B, electrospray ionization mass spectrometry (ESI MS) could be applied in addition to size exclusion chromatography (SEC). These two techniques enabled us to separate and detect distinguished oligomers from the monomers: dimers, trimers, tetramers, up to decamers. The amyloid fibril formation process was followed at different pH and temperatures, including such conditions where the process was slow enough to detect the initial oligomeric species at the very beginning of the lag phase and those at the end of the lag phase. Taking into account the results of the lower-order oligomers transformations early in the process, we were able to propose an improved model for the stefin B fibril formation. MDPI 2013-09-05 /pmc/articles/PMC3794784/ /pubmed/24013380 http://dx.doi.org/10.3390/ijms140918362 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland http://creativecommons.org/licenses/by/3.0 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Article Taler-Verčič, Ajda Kirsipuu, Tiina Friedemann, Merlin Noormägi, Andra Polajnar, Mira Smirnova, Julia Žnidarič, Magda Tušek Žganec, Matjaž Škarabot, Miha Vilfan, Andrej Staniforth, Rosemary A. Palumaa, Peep Žerovnik, Eva The Role of Initial Oligomers in Amyloid Fibril Formation by Human Stefin B |
title | The Role of Initial Oligomers in Amyloid Fibril Formation by Human Stefin B |
title_full | The Role of Initial Oligomers in Amyloid Fibril Formation by Human Stefin B |
title_fullStr | The Role of Initial Oligomers in Amyloid Fibril Formation by Human Stefin B |
title_full_unstemmed | The Role of Initial Oligomers in Amyloid Fibril Formation by Human Stefin B |
title_short | The Role of Initial Oligomers in Amyloid Fibril Formation by Human Stefin B |
title_sort | role of initial oligomers in amyloid fibril formation by human stefin b |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794784/ https://www.ncbi.nlm.nih.gov/pubmed/24013380 http://dx.doi.org/10.3390/ijms140918362 |
work_keys_str_mv | AT talervercicajda theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT kirsipuutiina theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT friedemannmerlin theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT noormagiandra theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT polajnarmira theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT smirnovajulia theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT znidaricmagdatusek theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT zganecmatjaz theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT skarabotmiha theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT vilfanandrej theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT staniforthrosemarya theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT palumaapeep theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT zerovnikeva theroleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT talervercicajda roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT kirsipuutiina roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT friedemannmerlin roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT noormagiandra roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT polajnarmira roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT smirnovajulia roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT znidaricmagdatusek roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT zganecmatjaz roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT skarabotmiha roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT vilfanandrej roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT staniforthrosemarya roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT palumaapeep roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb AT zerovnikeva roleofinitialoligomersinamyloidfibrilformationbyhumanstefinb |